CRHR2 and cancer: However, identifying the signaling pathway CRHR2/Ucn2 as a critical negative regulator of colonic inflammation and malignancy, allows us to begin thinking about the inclusion of low CRHR2 expression levels in the colon in the list of novel putative prognostic indicators for sustaining chronic inflammation and promoting cancer development and aggressiveness in the organ.